London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

Top Shelf Botanicals Opens 14th Location in Three Forks

THREE FORKS, Mont., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Top Shelf Botanicals, Inc. ("TSB"; a